19:50 EST Bluebird Bio (BLUE) trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLUE:
- Largest borrow rate increases among liquid names
- Bluebird Bio presents long-term data on LYFGENIA gene therapy for SCD
- CMS to work with Vertex, blubird to improve access to therapies, Reuters reports
- Bluebird Bio announces 1-for-20 reverse stock split
- Bluebird Bio participates in CMMI Cell and Gene Therapy Access Model